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Y chromosome microdeletions are the most frequent gen-
etic cause of severe oligozoospermia (<5 million sperma-
tozoa ml)1) and azoospermia (absence of spermatozoa in
the ejaculate) (for review see Krausz et al., 2003 and ref-
erences therein). The Y microdeletions associated with
infertility occur in specific regions of the long arm of the
Y called azoospermia factor (AZF) regions (Tiepolo &
Zuffardi, 1976). Originally, three types of AZF deletion
(AZFa, AZFb and AZFc) have been described by Vogt
et al. (1996); however, after the complete physical map
and sequence of the AZFb and AZFc regions, it became
evident that the AZFb and AZFc intervals are partially
overlapping (Repping et al., 2002). The Y chromosome is
extremely rich of repetitive sequences organized in ampli-
cons. Ampliconic sequences are characterized by sequence
pairs showing nearly complete (>99.9%) nucleotide iden-
tity, organized in massive palindromes. These repeated
sequences may undergo genetic exchange through gene
conversion, i.e. nonreciprocal transfer of sequence infor-
mation occurring between duplicated sequences within
the chromosome, a process that could account for the
>99.9% nucleotide identity between the arms of a palin-
drome. Although this mechanism may serve to preserve Y
genes from the gradual accumulation of deleterious muta-
tions and thus prolong their genetic fitness, this peculiar
organization also provides the structural basis for dele-
tions and rearrangements.
The complete Y chromosome sequence and its gene
content has now been published in GenBank. The human
Y chromosome contains mainly gene encoding factors,
which are essential for male fertility. Although the major-
ity of the AZF candidate genes have been identified years
ago, their exact function and role in spermatogenesis
remain unclear (for review see Skaletsky et al., 2003 and
references therein).
Despite this fact, after resolving many initial contra-
dictory issues such as specificity of Y deletions, variability
in deletion frequency, markers to be tested, genotype–
phenotype correlation, the essential role of Y chromo-
some related factors in the spermatogenetic process, and
thus the clinical significance of AZF deletions have been
well established.
Clinical significance of Y deletions
Are Y deletions specific for spermatogenic failure?
The aetiopathogenetic role of Y deletions in male
infertility has been questioned by reports describing Y
microdeletions in ‘proven fertile men’, however, appropri-
ate studies using normospermic men as controls and not
‘fertile subjects with unknown sperm count’, have high-
lighted that AZF deletions are specific for spermatogenic
failure (see Krausz & McElreavey, 2001 and references
therein).
What is the frequency of this genetic anomaly among
infertile men?
The incidence of Y deletions varies enormously among
studies from 1 to 55%. Many of the initial studies suf-
fered from technical problems, and papers presenting a
mosaic type of pattern of deletions, especially with dele-
tions of single sequence tag sites (STS) without confirma-
tion are of dubious significance. Apart from the lack of
rigorous testing of negative results or inappropriate
choice of markers, other factors such as differences in the
composition of the study populations (clinical character-
istics and ethnic background) have been evoked to
explain this variability. We studied four different popula-
tions using a similar set of markers and similar clinical
criteria for the definition of patients. It was demonstrated
that the main factor influencing deletion frequency is the
composition of the study population (highest frequency
found in the two studies with the largest number of azoo-
spermic men included) rather than the ethnic origin of a
given population (Krausz et al., 1999a,b, 2001a, 2003).
The incidence of Y deletions is 10–15% in azoospermic
men and 5–10% in oligospermic men.
Which category of patients has to be tested?
Y deletions have been found almost exclusively in patients
with <1 million spermatozoa ml)1 and are extremely rare
with a sperm concentration of >5 million spermato-
zoa ml)1 (approximately 0.7%). Deletions have also been
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found (7%) as ‘chance association’ in the presence of
other abnormal andrological findings such as varicocele,
cryptorchidism, hypogonadotrophic hypogonadism, etc.
(Krausz et al., 1999b).
In two studies of the Danish population, complete hor-
monal analysis was available in all patients and serum
inhibin B concentration was uniformly below the normal
range in patients with microdeletions because of their
severe spermatogenic impairment (Krausz et al., 2001a;
Frydelund-Larsen et al., 2002). In a large study by Tomasi
et al. (2003), inhibin B and follicle-stimulating hormone
levels were undistinguishable in patients with idiopathic
and microdeletion-associated oligo/azoospermia. These
data do not support the hypothesis proposed by another
group (Foresta et al., 2002) that microdeleted patients
have a less severe impairment of Sertoli cell function than
patients with idiopathic oligo/azoospermia.
Therefore, indications for AZF microdeletion analysis
are sperm concentrations of <5 million sper-
matozoa ml)1.
Is there any genotype–phenotype correlation?
Deletions removing the entire AZFa or AZFb regions
(‘complete’ deletions) are associated with Sertoli cell only
syndrome (SCOS) (Kamp et al., 2001) and spermatogenic
arrest (Vogt et al., 1996; Krausz et al., 2000; Hopps et al.,
2003) respectively. Partial deletions of these regions or
complete or partial AZFc deletions are associated with a
variable phenotype ranging from hypospermatogenesis
(oligozoospermia) to SCOS (azoospermia). A possible
explanation for such a variable phenotype is a progressive
regression of the germinal epithelium over time, which
has been reported in patients with AZFc deletions. An
alternative explanation for the variable phenotype is rela-
ted to influences of the genetic background and environ-
mental factors in different individuals.
Which markers have to be tested?
The most frequently deleted region is AZFc (approxi-
mately 60%) followed by deletions of the AZFb and
AZFb + c or AZFa + b + c regions (35%) whereas dele-
tions of the AZFa region are extremely rare (5%). For
diagnostic purposes, it is important to use a relatively
small number of well-chosen markers, which cover all the
three AZF regions (Simoni et al., 2004). It is still debated
if gene-specific deletion screening, which theoretically is
more appropriate, gives any advantage in the clinical man-
agement of the patients. The absence of isolated gene spe-
cific deletions in >1600 severe male factor patients are
suggestive of no practical advantage (see for review Krausz
et al., 2003 and references therein; Silber et al., 1998).
Once a deletion is found, it is important to define with
a second set of primers, the extension of the deletion espe-
cially in case of AZFa and AZFb deletions (see below).
What is the clinical significance of Yq deletions?
The identification of Y deletions has a diagnostic, prog-
nostic and preventive value as: (i) the presence of Y
microdeletions explains the aetiology of infertility and
thereby helps avoid unnecessary medical and surgical
treatments (for e.g. correction of varicocele, Cayan et al.,
2001); (ii) in azoospermic men, the presence of a complete
AZFa or AZFb deletion has a negative prognostic value for
testicular sperm retrieval (Brandell et al., 1998; Krausz
et al., 2000; Hopps et al., 2003); (iii) in patients presenting
oligozoospermia who are at risk for a progressive decrease
of sperm concentration over time, cryopreservation of
spermatozoa could avoid future more invasive techniques
such as testicular sperm extraction/intracytoplasmic sperm
injection (TESE/ICSI) (Krausz & McElreavey, 1999).
Genetic counselling
Are spermatozoa bearing Y chromosome microdeletions
fully fertile?
Spermatozoa from patients with Yq microdeletions have
been found to be fully fertile both following IVF and ICSI
procedures and even by natural conception. However, it
is not clear if the fertilization rate and embryo develop-
ment are comparable with that observed in men without
deletions.
What will be the phenotype of the son?
After conception, Y deletion is obligatory transmitted to
the male offspring. The phenotype of son may vary sub-
stantially, and the extent of spermatogenic failure cannot
be predicted entirely because of different genetic back-
ground, and the presence or absence of environmental
factors with potential toxicity to reproductive function.
Is there any other risk than infertility?
We have previously reported that a significant proportion
of spermatozoa from men with Y microdeletion are nulliso-
mic for sex chromosomes (Siffroi et al., 2000). This result
indicates a potential risk for the offspring to develop 45,X0
Turner’s syndrome and other phenotypic anomalies associ-
ated with sex chromosome mosaicism including ambigu-
ous genitalia. Screening for Y chromosome microdeletions
in patients bearing a mosaic 46XY/45X0 karyotype with
sexual ambiguity and/or Turner stigmata has shown a relat-
ively high incidence of AZFc deletions (33%, Patsalis et al.,
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2002). These data suggest that some Yq microdeletions are
associated with an overall Y chromosomal instability lead-
ing to the formation of 45,X0 cell lines. Until now, only
16 male and eight female ICSI babies born from fathers
affected by Yq microdeletions have been reported. It
appears that the children are phenotypically normal (except
one son born with pulmonary atresia and a hypoplastic
right ventricle, Page et al., 1999) and no ambiguous genita-
lia or Turner’s syndrome have been observed among them.
Considering that embryos bearing a 45,XO karyoptye have
a higher risk of spontaneous abortion, it would be import-
ant to know whether among the partners of Y deleted men
there is a higher incidence of spontaneous abortion. If this
is the case, pre-implantation diagnosis could be offered to
the couple.
The gr/gr deletions
The classical AZFc deletion, which removes 3.5 Mb
between the b2/b4 amplicons is the most frequent type
of deletion. Considering the Y structure and the suggested
deletion mechanism, a number of other possible par-
tial deletions have been proposed both in the AZFb and
AZFc regions. The frequency and the pathological signifi-
cance of these partial deletions is not yet clear, although a
partial deletion termed ‘gr/gr’ has been described specific-
ally in infertile men with varying degrees of spermatogenic
failure (Repping et al., 2003). This deletion removes half
the AZFc gene content including two copies of the major
AZFc candidate gene called DAZ (deleted in azoospermia).
Another deletion named ‘b2/b3’ (Repping et al., 2004) or
‘u3-gr/gr’ (Machev et al., 2004) or ‘g1/g3’ (Fernandes
et al., 2004), which removes a similar quantity of AZFc
genes seems to have no effect on fertility status in associ-
ation with a certain Y chromosome background com-
monly present in Northern Eurasian populations (Y
haplogroup N). A similar conclusion can also be drawn
for the ‘gr/gr’ deletion found in association with Hgr D2b,
which is present in 20% of Japanese men. It is therefore
possible that the type and number of missing gene copies
or other unknown Y related factors (for example duplica-
tions or beneficial mutations in other parts of the Y chro-
mosome) may also influence the phenotype.
We studied a large group of normospermic (n ¼ 189)
and oligo/azoospermic (n ¼ 150) men using an STS plus/
minus method. Our analysis showed that: (i) partial AZFc
deletions are not specific for spermatogenic failure; (ii)
‘gr/gr’ deletion can be considered as a risk factor, as its
frequency was significantly higher in the oligo/azoosper-
mic group (5.3%) with respect to controls (0.5%)
P < 0.012. Gene-specific analysis revealed three distinct
deletion patterns, indicating that further combined studies
based on gene copy and haplogroup analysis are likely to
provide a means for the distinction between pathogenic
and neutral (or compensated by other Y factors) deletion
types (Giachini et al., 2005).
Y chromosome and genetic susceptibility
to infertility
For a number of years, different lineages of the human Y
chromosome have been used extensively by human popu-
lation geneticists to trace population movements and
understand human origins and histories. Positive selection
(such as increased fecundity) or negative selection
(reduced fertility) on the Y chromosome can be deter-
mined by screening for associations between Y chromo-
some haplogroups and male-specific phenotypes such as
infertility or germ cell cancer. It is now possible to use a
wide variety of molecular tools to explore questions rela-
ted to the Y chromosome and male reproductive fitness.
We and others have applied Y chromosome haplogroup
distributions in study and control populations to under-
stand the relationship between different classes of Y chro-
mosome and susceptibility to AZF microdeletions and
reduced sperm counts. (i) Y chromosome microdeletions
were found to occur on different Y chromosome back-
grounds, and there was no significant difference between
Y chromosome haplogroup distribution in the study and
control groups. However, the number of AZFa deletions
included in the studies was small and it remains to be
seen if there is predisposing class of Y-chromosomes for
this type of deletion (Paracchini et al., 2000; Quintana-
Murci et al., 2001). (ii) The association between Y chro-
mosome haplogroups and sperm counts has been
explored in three populations, the Danish, Japanese and
Italian. In Denmark, a study of men with <20 · 106 sper-
matozoa ml)1 revealed a significant overrepresentation
of haplogroup 26 (Krausz et al., 2001b). In the Japanese
and Italian populations, the results are mixed both the
presence (Kuroki et al., 1999) and absence (Paracchini
et al., 2002) of predisposing Y haplogroups have been
reported.
Conclusions
The screening for Yq deletions became part of the routine
diagnostic work-up of severe male factor infertility in
many assisted reproductive technique and andrology clin-
ics. Although the indications for testing and the markers
to be used are well defined, many laboratories are produ-
cing unreliable results. If we exclude ‘unusual deletions’
found only in certain laboratories, the minimal set of
primers proposed by the European Academy of Androl-
ogy (Simoni et al., 2004) is able to detect almost 100% of
clinically relevant deletions.
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Future studies are addressed to the definition of the
function of Y genes in spermatogenesis and the incidence
of their intragenic mutations. An other challenging area
with potential clinical value concerns the reduction of
single copies of multicopy AZF genes and the definition
of pathogenic gr/gr deletions.
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